Two of our favourite products, Amphibian and Infrared, now officially have the title of the best!
Estetica.hr portal and the Estetica Premium Product project, along with the most respectable Croatian dermatologists, have included Skintegra's products in the leading premium products of 2021.
A team of dermatological experts did not have an easy task; several months of studying formulations, product testing and choosing the best - guided solely by the quality of ingredients and the effect achieved.
In the BEST PRODUCT AGAINST ROSACEA category, our concentrated soothing Infrared serum stood out.
Skintegra Infrared Superpotent Skin Supporting & Correcting Concentrate
“We’ve got another highly potent ally to fight rosacea, an incurable skin condition that needs to be kept under control. Thanks to azelaic acid derivative, niacinamide, panthenol, antioxidants and excellent texture, this product should become a part of your daily routine. It can be introduced gradually, and after a while the real effect of this powerful product can be seen ", praised Dr. Nevia Delalle.
Dr. Jelena Jakić is also delighted with Infrared: “Soothing and hydrating serum for inflammation-prone skin, light, moisturizing texture, does not make your skin oily nor does it leave a heavy feeling on the skin. Patients are satisfied, it does not irritate their skin and it is great for long-term use. ”
Innovative and gentle Amphibian won in the BEST FACE CLEANER AND MAKE-UP REMOVER FOR PROBLEMATIC SKIN category.
Skintegra Amphibian Calming Hydrating Aqua Jelly Cleansing Gel
Dr. Nevia Delalle had this to say about our gentle cleanser: “Amphibian is another Skintegra product that I liked. I actually like both the packaging and the smell and the way it is used. A gel-like texture that turns to foam and removes make-up well, as well as heavy, professional one. After cleansing, the skin is still hydrated and does not require more care than usual.”
Guided by the idea of healthy skin, we are proud and grateful for this recognition by respectable dermatologists.
